Felicia Cosman MD

Dr. Cosman joined Helen Hayes Hospital in West Haverstraw, New York in 1988 where she serves as an osteoporosis specialist, clinical scientist, and Medical Director of the Clinical Research Center. She is also a Professor of Clinical Medicine at Columbia University. Her research has included studies on the causes of osteoporosis and how estrogen, SERMS, vitamin D, bisphosphonates, teriparatide, and denosumab work as treatments for osteoporosis. She has also studied the causes of stress fractures and factors influencing the acquisition of peak bone mass in young military cadets at the United States Military Academy.

Dr. Cosman has been involved in many research studies evaluating the effectiveness and safety of investigational osteoporosis medications. Her major research focus over the last decade is the use of teriparatide, a bone-building medication, in combination with antiresorptive agents, and in novel cyclic regimens, in the treatment of severe osteoporosis.

She is the recipient of research grants from the National Institutes of Health, the Department of Defense, the National Multiple Sclerosis Society, and multiple pharmaceutical companies. Dr. Cosman has published over 130 peer-reviewed articles in the osteoporosis field, in journals including the New England Journal of Medicine and the Journal of the American Medical Association. She is the author of "What Your Doctor May Not Tell You About Osteoporosis (Warner Books)" and co-editor of "Osteoporosis: An Evidence-Based Approach to the Prevention of Fractures (American College of Physicians)". She has also contributed countless chapters to textbooks of endocrinology, rheumatology, gynecology, and internal medicine and has served on multiple international task forces including the ASBMR task force on atypical femur fractures and the ASBMR/NOF task force on Goal-Directed Osteoporosis Therapy.